PANE, CHIARA
 Distribuzione geografica
Continente #
AS - Asia 1.873
NA - Nord America 1.858
EU - Europa 1.450
SA - Sud America 247
Continente sconosciuto - Info sul continente non disponibili 97
AF - Africa 56
OC - Oceania 1
Totale 5.582
Nazione #
US - Stati Uniti d'America 1.781
SG - Singapore 778
RU - Federazione Russa 608
IT - Italia 418
VN - Vietnam 376
CN - Cina 375
BR - Brasile 191
HK - Hong Kong 148
DE - Germania 81
NL - Olanda 68
FR - Francia 66
GB - Regno Unito 48
CA - Canada 42
FI - Finlandia 40
BD - Bangladesh 39
IN - India 35
IE - Irlanda 28
JP - Giappone 25
MX - Messico 23
AR - Argentina 21
KR - Corea 20
EC - Ecuador 14
BG - Bulgaria 13
SE - Svezia 13
ZA - Sudafrica 13
CI - Costa d'Avorio 12
AT - Austria 11
IQ - Iraq 11
ES - Italia 10
TR - Turchia 10
PH - Filippine 9
UA - Ucraina 9
CO - Colombia 8
PL - Polonia 8
TW - Taiwan 8
KE - Kenya 7
MA - Marocco 7
TH - Thailandia 6
CH - Svizzera 5
ID - Indonesia 5
MK - Macedonia 5
EG - Egitto 4
ET - Etiopia 4
PK - Pakistan 4
VE - Venezuela 4
AL - Albania 3
BE - Belgio 3
CL - Cile 3
MY - Malesia 3
RO - Romania 3
SA - Arabia Saudita 3
UZ - Uzbekistan 3
AZ - Azerbaigian 2
CZ - Repubblica Ceca 2
DO - Repubblica Dominicana 2
IR - Iran 2
JM - Giamaica 2
LV - Lettonia 2
PY - Paraguay 2
RS - Serbia 2
AE - Emirati Arabi Uniti 1
AO - Angola 1
AP - ???statistics.table.value.countryCode.AP??? 1
AU - Australia 1
BB - Barbados 1
BH - Bahrain 1
BO - Bolivia 1
CG - Congo 1
CR - Costa Rica 1
CW - ???statistics.table.value.countryCode.CW??? 1
DM - Dominica 1
EE - Estonia 1
EU - Europa 1
GA - Gabon 1
GF - Guiana Francese 1
HN - Honduras 1
HR - Croazia 1
IL - Israele 1
JO - Giordania 1
KN - Saint Kitts e Nevis 1
KW - Kuwait 1
KZ - Kazakistan 1
LT - Lituania 1
MZ - Mozambico 1
NG - Nigeria 1
NI - Nicaragua 1
NO - Norvegia 1
NP - Nepal 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
PS - Palestinian Territory 1
RW - Ruanda 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
UY - Uruguay 1
VC - Saint Vincent e Grenadine 1
YE - Yemen 1
YT - Mayotte 1
ZW - Zimbabwe 1
Totale 5.488
Città #
Singapore 398
San Jose 381
Ashburn 180
Moscow 151
Chandler 143
Hong Kong 137
Beijing 104
Hefei 103
Ho Chi Minh City 96
Hanoi 79
Naples 60
Santa Clara 60
Council Bluffs 58
Amsterdam 44
The Dalles 43
Lauterbourg 33
Dallas 30
Seattle 30
Milan 29
New York 29
Los Angeles 28
Millbury 26
Nanjing 25
Munich 24
Buffalo 22
Da Nang 22
Rome 22
Tokyo 21
Des Moines 19
Dearborn 18
Seoul 18
Boston 17
Frankfurt am Main 17
Napoli 17
São Paulo 17
Haiphong 16
Princeton 16
Turku 16
Redondo Beach 14
Nola 13
Sofia 12
Bollate 11
Mexico City 11
San Francisco 11
Toronto 11
Atlanta 10
Houston 10
Lawrence 10
Norwalk 10
Orem 10
Biên Hòa 9
Dublin 9
Helsinki 9
Montreal 9
Phoenix 9
Can Tho 8
Cava De' Tirreni 8
Chicago 8
Shenyang 8
Stockholm 8
Charlotte 7
Denver 7
Florence 7
Gricignano di Aversa 7
Johannesburg 7
Le Cannet 7
Poplar 7
Pune 7
Vienna 7
Warsaw 7
Wilmington 7
Baghdad 6
Bến Tre 6
Chennai 6
Curitiba 6
Jacksonville 6
London 6
Turin 6
Bexley 5
Brooklyn 5
Falkenstein 5
Giugliano in Campania 5
Manchester 5
Monteforte Irpino 5
Mumbai 5
Nairobi 5
Nuremberg 5
Ottawa 5
Padova 5
Quito 5
Thái Nguyên 5
Tianjin 5
Washington 5
Afragola 4
Bangkok 4
Belo Horizonte 4
Bologna 4
Brasília 4
Columbus 4
Dong Ket 4
Totale 2.989
Nome #
GAA-FGF14 ataxia (SCA27B): phenotypic profile, natural history progression and 4-aminopyridine treatment response 318
A real-life experience with eculizumab and efgartigimod in generalized myasthenia gravis patients 208
Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial 184
Safety and feasibility of upper limb cardiopulmonary exercise test in Friedreich ataxia 176
A randomized controlled pilot trial of lithium in spinocerebellar ataxia type 2. 174
The use of medical-grade cannabis in patients non-responders to Nabiximols 170
Cerebellum and cognition in Friedreich ataxia: a voxel-based morphometry and volumetric MRI study 163
Emotion Recognition and Psychological Comorbidity in Friedreich’s Ataxia 160
Prevalence and features of non-motor symptoms in Wilson's disease 160
Long-term effect of epoetin alfa on clinical and biochemical markers in friedreich ataxia 157
Rationale and protocol of a double-blind, randomized, placebo-controlled trial to test the efficacy, safety, and tolerability of dimethyl fumarate in Friedreich Ataxia (DMF-FA-201) 156
Screening for Fabry disease in a series of Parkinson’s disease patients and literature review 156
Motor and non-motor features in Parkinson's Disease patients carrying GBA gene mutations 153
The C-Terminal Cross-linked Telopeptide of Type I Collagen (CTX-I) as a Potential Cardiomyopathy Biomarker in Friedreich Ataxia Patients 149
Dimethyl Fumarate Mediates Nrf2-dependent Mitochondrial Biogenesis in Mice and Humans 149
Lamivudine and fingolimod co-administration in two patients with multiple sclerosis and occult hepatitis B virus infection 142
Adult normative values for the PATA Rate Test 141
Peripheral markers of autophagy in polyglutamine diseases 140
Application of the p9NORM correction method to timed neuropsychological tests in Parkinson's disease and multiple system atrophy. 140
Stability of erythropoietin repackaging in polypropylene syringes for clinical use 135
A randomized clinical trial of lithium in multiple system atrophy. 134
Mobitz type I and II atrioventricular blocks during fingolimod therapy 134
Dimethyl fumarate dosing in humans increases frataxin expression: A potential therapy for Friedreich’s Ataxia 131
Efficacy of innovative therapies in myasthenia gravis: A systematic review, meta-analysis and network meta-analysis 130
A new genetic cause of spastic ataxia: the p.Glu415Lys variant in TUBA4A 128
Othello syndrome in Parkinson's disease: a systematic review and report of a case series 127
Conventional MRI findings in hereditary degenerative ataxias: a pictorial review 127
The EDSS integration with the Brief International Cognitive Assessment for Multiple Sclerosis and orientation tests 124
The Multiple Faces of Spinocerebellar Ataxia type 2 121
Screening for RFC-1 pathological expansion in late-onset ataxias: a contribution to the differential diagnosis. 120
Normalization of timed neuropsychological tests with the PATA rate and nine-hole pegboard tests 118
Dissociative Identity Disorder: Restoration of Executive Functions After Switch from Alter to Host Personality. 115
Gradient of microstructural damage along the dentato‐thalamo‐cortical tract in Friedreich ataxia 111
Ataxia and Hypogonadism: a Review of the Associated Genes and Syndromes. 110
Fingolimod first dose safety in clinical practice. 107
Correction to: Peripheral markers of autophagy in polyglutamine diseases (Neurological Sciences, (2018), 39, 1, (149-152), 10.1007/s10072-017-3156-6) 103
Altered Intracerebellar Functional Connectivity in Friedreich's Ataxia: A Graph-Theory Functional MRI Study 96
Brain Structure and Degeneration Staging in Friedreich Ataxia: Magnetic Resonance Imaging Volumetrics from the ENIGMA-Ataxia Working Group 81
The use of medical grade cannabis in Italy for drug-resistant epilepsy: a case series 62
Nonvascular Parkinsonism in Fabry Disease: Results from Magnetic Resonance and Dopamine Transporter Imaging 49
null 23
Totale 5.582
Categoria #
all - tutte 17.017
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.017


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022179 0 0 1 1 5 10 6 5 31 13 37 70
2022/2023344 36 37 13 19 40 33 9 28 58 52 16 3
2023/2024256 7 33 17 21 14 25 13 55 7 2 32 30
2024/20251.367 51 31 9 30 63 63 163 94 95 121 528 119
2025/20262.808 251 276 307 271 463 123 322 150 272 177 118 78
2026/2027294 149 142 3 0 0 0 0 0 0 0 0 0
Totale 5.582